Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium

Journal of Cardiovascular Pharmacology

Volumn 61, Issue 3, 2013, Pages 258-263

  Chaudhary, Ketul R ^a   Cho, Woo Jung ^a   Yang, Fenghua ^a   Samokhvalov, Victor ^a   El Sikhry, Haitham E ^a   Daniel, Edwin E ^a   Seubert, John M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; CAVEOLIN 1; CAVEOLIN 3; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIUM; CAVEOLA; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE RELEASE; DRUG MECHANISM; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPERFUSION INJURY; TISSUE STRUCTURE;

ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CAVEOLAE; CAVEOLIN 1; CAVEOLIN 3; EICOSANOIDS; EPOXIDE HYDROLASES; HEART; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERFUSION; SIGNAL TRANSDUCTION;

EID: 84875221108     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31827afcee     Document Type: Article

References (19)

1. Patel HH, Murray F, Insel PA. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol. 2008;48:359-391.
2. Cho WJ, Chow AK, Schulz R, et al. Caveolin-1 exists and may function in cardiomyocytes. Can J Physiol Pharmacol. 2010;88:73-76.
3. Patel HH, Tsutsumi YM, Head BP, et al. Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1. Faseb J. 2007;21:1565-1574.
4. Jasmin JF, Rengo G, Lymperopoulos A, et al. Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. Am J Physiol Heart Circ Physiol. 2011;300: H1274-H1281.
5. Horikawa YT, Patel HH, Tsutsumi YM, et al. Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J Mol Cell Cardiol. 2008; 44:123-130.
6. Tsutsumi YM, Horikawa YT, Jennings MM, et al. Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation. 2008;118:1979-1988.
7. Wang Y, Wang X, Jasmin JF, et al. Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection. Arterioscler Thromb Vasc Biol. 2012;32:934-942.
8. Ballard-Croft C, Locklar AC, Kristo G, et al. Regional myocardial ischemiainduced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterol. Am J Physiol Heart Circ Physiol. 2006;291: H658-H667.
9. Koneru S, Penumathsa SV, Thirunavukkarasu M, et al. Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am J Physiol Heart Circ Physiol. 2007;292:H2060-H2072.
10. Tsutsumi YM, Kawaraguchi Y, Horikawa YT, et al. Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection. Anesthesiology. 2010;112:1136-1145.
11. Fleming I, Rueben A, Popp R, et al. Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells. Arterioscler Thromb Vasc Biol. 2007;27:2612-2618.
12. Seubert JM, Zeldin DC, Nithipatikom K, et al. Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. Prostaglandins Other Lipid Mediat. 2007;82:50-59.
13. Katragadda D, Batchu SN, Cho WJ, et al. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells. J Mol Cell Cardiol. 2009;46:867-875.
14. Chaudhary KR, Batchu SN, Das D, et al. Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function. Cardiovasc Res. 2009;83:362-370
15. Seubert JM, Sinal CJ, Graves J, et al. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res. 2006;99: 442-450.
16. Spector AA, Norris AW. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell physiol. 2007;292:C996-C1012.
17. Miyasato SK, Loeffler J, Shohet R, et al. Caveolin-1 modulates TGF-beta1 signaling in cardiac remodeling. Matrix Biol. 2011;30:318-329.
18. Park DS, Woodman SE, Schubert W, et al. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol. 2002;160:2207-2217.
19. Schubert W, Sotgia F, Cohen AW, et al. Caveolin-1(-/-)- and caveolin-2 (-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation. Am J Pathol. 2007;170:316-333.